Russia’s Sputnik V vaccine is still waiting for the European Medicines Agency to start the countdown to its launch across the 27-nation bloc.
This first stage is a “rolling review” of data and trials, which the EMA says Sputnik has not started.“They have to submit the whole set of data, indeed go through the whole scrutiny process, like any other vaccine,” European Commission chief Ursula von der Leyen said on February 17 about Sputnik. The EMA has however said that Sputnik V’s backers submitted a request for “scientific advice” to prepare for a possible application for market authorisation, and confirmed a meeting took place on January 19 to discuss “further engagement”.Russian authorities tout the vaccine’s take-up by around 30 countries and a Lancet study showing it was 91.6 percent effective against symptomatic Covid-19 cases.
The fund insisted it was “working with the EMA to start a rolling review” and said the agency had a few days ago “appointed rapporteurs for the Sputnik V dossier”.As it would be the first non-Western developed vaccine deployed in the EU, officials have said that Sputnik production sites outside the bloc would need to be inspected.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.